Introduction
This guidance helps sport and physical activity professionals understand GLP‑1 and other weight‑management medications, their physiological effects, and implications for exercise. It emphasises tailoring programmes to manage side effects, preserving muscle through resistance training and adequate protein, and supporting clients with safe, gradual progression. Professionals are reminded to stay within scope, avoid giving medical advice, recognise red flags, and signpost to healthcare providers when needed. The document also calls for improved workforce training and collaboration with healthcare to ensure safe, effective support for individuals using weight‑management medications.
